Skip to content
Menu

Medifast Sees FY2026 Adj EPS $(0.70)-$(0.45) vs $(0.94) Est; Raises FY2026 Sales Guidance from $270.000M-$300.000M to $280.000M-$300.000M vs $287.700M Est

Benzinga Newsdesk 3 weeks ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Medifast (NYSE:MED) is looking for FY2026 Adj EPS of $(0.70)-$(0.45) vs $(0.94) analyst estimate. Raises FY2026 sales outlook from $270.000 million-$300.000 million to $280.000 million-$300.000 million vs $287.700

Medifast (NYSE:MED) is looking for FY2026 Adj EPS of $(0.70)-$(0.45) vs $(0.94) analyst estimate. Raises FY2026 sales outlook from $270.000 million-$300.000 million to $280.000 million-$300.000 million vs $287.700 million estimate.

Read at benzinga.com

← All stock news